首页 > 最新文献

Explore-The Journal of Science and Healing最新文献

英文 中文
Cranberries for preventing urinary tract infections: Summary of a Cochrane review 蔓越莓预防尿路感染:科克伦综述摘要
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.explore.2024.103045
Amrita Bonthu
{"title":"Cranberries for preventing urinary tract infections: Summary of a Cochrane review","authors":"Amrita Bonthu","doi":"10.1016/j.explore.2024.103045","DOIUrl":"10.1016/j.explore.2024.103045","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103045"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1550830724001526/pdfft?md5=1b4f4d8d1c63ed820ff6c50d3870a103&pid=1-s2.0-S1550830724001526-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142239284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Masthead page 刊头页面
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/S1550-8307(24)00158-7
{"title":"Masthead page","authors":"","doi":"10.1016/S1550-8307(24)00158-7","DOIUrl":"10.1016/S1550-8307(24)00158-7","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 5","pages":"Article 103051"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A patient with out-of-hospital cardiac arrest saved from heart transplantation and amputation through a collaboration between modern and traditional Chinese medicine: A case report 中西医结合治疗院外心脏骤停患者,使其免于心脏移植和截肢:病例报告
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-23 DOI: 10.1016/j.explore.2024.103043
Wan-Ting Soong , Shih-Ying Sung , Sunny Jui-Shan Lin

Introduction

Patients with end-stage heart failure have limited options for medical treatment, and this ultimately necessitates heart transplantation. Patients undergoing heart transplant surgery are burdened with substantial costs related to finances, procedural risks, and postoperative quality of life. This report presents a case of heart failure in a patient whose limbs and heart were preserved through a collaboration between modern and traditional Chinese medicine (TCM).

Patient Presentation

A 47-year-old man was admitted to the emergency department with out-of-hospital cardiac arrest (OHCA) and was diagnosed with 3-vessel disease and acute decompensated heart failure on October 27, 2020. After extracorporeal membrane oxygenation (ECMO), the patient presented with cyanosis and gangrene in all four limbs. Cardiologists and plastic surgeons recommended heart transplantation and amputation. The patient wanted to keep his limbs and heart intact and requested to receive TCM. A TCM physician was consulted by visiting staff to provide combined care. After TCM intervention, both the ejection fraction (EF) and gangrene improved. Until now, the patient continues to receive TCM treatment, lives with preserved limbs and heart, and went through SARS-CoV2 infection smoothly in 2023.

Conclusion

TCM met the expectations of the patient and reduced the high medical expenses. This approach may improve the outlook and be a more economical option for patients with end-stage heart failure.

导言终末期心力衰竭患者的药物治疗选择有限,最终不得不接受心脏移植手术。接受心脏移植手术的患者要承担与经济、手术风险和术后生活质量相关的大量费用。本报告介绍了一例通过现代和传统中医药(TCM)合作保留肢体和心脏的心力衰竭患者。 患者介绍 一名 47 岁男子因院外心脏骤停(OHCA)被送入急诊科,并于 2020 年 10 月 27 日被诊断为三血管疾病和急性失代偿性心力衰竭。体外膜肺氧合(ECMO)后,患者出现发绀和四肢坏疽。心脏病专家和整形外科医生建议进行心脏移植和截肢手术。患者希望保留完整的四肢和心脏,并要求接受中医治疗。出诊人员咨询了一名中医师,以提供综合护理。经过中医干预,射血分数(EF)和坏疽都得到了改善。直到现在,患者仍在继续接受中医治疗,保留了肢体和心脏,并在 2023 年顺利度过了 SARS-CoV2 感染期。这种方法可以改善终末期心力衰竭患者的前景,是一种更经济的选择。
{"title":"A patient with out-of-hospital cardiac arrest saved from heart transplantation and amputation through a collaboration between modern and traditional Chinese medicine: A case report","authors":"Wan-Ting Soong ,&nbsp;Shih-Ying Sung ,&nbsp;Sunny Jui-Shan Lin","doi":"10.1016/j.explore.2024.103043","DOIUrl":"10.1016/j.explore.2024.103043","url":null,"abstract":"<div><h3>Introduction</h3><p>Patients with end-stage heart failure have limited options for medical treatment, and this ultimately necessitates heart transplantation. Patients undergoing heart transplant surgery are burdened with substantial costs related to finances, procedural risks, and postoperative quality of life. This report presents a case of heart failure in a patient whose limbs and heart were preserved through a collaboration between modern and traditional Chinese medicine (TCM).</p></div><div><h3>Patient Presentation</h3><p>A 47-year-old man was admitted to the emergency department with out-of-hospital cardiac arrest (OHCA) and was diagnosed with 3-vessel disease and acute decompensated heart failure on October 27, 2020. After extracorporeal membrane oxygenation (ECMO), the patient presented with cyanosis and gangrene in all four limbs. Cardiologists and plastic surgeons recommended heart transplantation and amputation. The patient wanted to keep his limbs and heart intact and requested to receive TCM. A TCM physician was consulted by visiting staff to provide combined care. After TCM intervention, both the ejection fraction (EF) and gangrene improved. Until now, the patient continues to receive TCM treatment, lives with preserved limbs and heart, and went through SARS-CoV2 infection smoothly in 2023.</p></div><div><h3>Conclusion</h3><p>TCM met the expectations of the patient and reduced the high medical expenses. This approach may improve the outlook and be a more economical option for patients with end-stage heart failure.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103043"},"PeriodicalIF":1.9,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review of inflammatory bowel disease from the perspective of Persian medicine 从波斯医学的角度回顾炎症性肠病。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-21 DOI: 10.1016/j.explore.2024.103041
Fatemeh sadat Hasheminasab , Maryam Azimi

The initial descriptions of inflammatory bowel disease (IBD) have been a topic of discussion. Cases of persistent diarrhea have been documented as far back as ancient Greece, with even Hippocrates (∼ 460–370 BCE) exploring various potential causes of diarrhea. Persian medicine was the predominant medical practice in the Eurasia region until the 18th century and had roots in Hippocrates and the ancient civilization of the region. Scholars, such as Avicenna (980–1025 CE), extensively described a disease characterized by intestinal ulcers, bloody diarrhea, and abdominal pain in the early medieval period. While some of the definitions and etiologies of IBD in Persian medicine are based on humoral theories that differ from current medical concepts, recent studies have suggested a potential relationship between the traditional Persian medicine understanding of the disease and IBD. Persian medicine classifies patients with specific diseases into different types of disorders known as dystemperament, with the application of these differences referred to as "syndrome differentiation." These traditional classifications require distinct therapeutic approaches. Research has delved into the molecular bases of the humoral theory and the impact of syndrome differentiation on drug selection for patients, including those with IBD. However, further research is needed to explore the potential effectiveness of Persian medicine in treating IBD and to understand how this ancient classification system can contribute to improved disease management.

关于炎症性肠病(IBD)的最初描述一直是人们讨论的话题。早在古希腊就有持续腹泻病例的记载,甚至希波克拉底(公元前 460-370 年)也探讨过腹泻的各种潜在原因。直到 18 世纪,波斯医学一直是欧亚地区的主要医学实践,其根源在于希波克拉底和该地区的古代文明。阿维森纳(公元 980-1025 年)等学者在中世纪早期广泛描述了一种以肠溃疡、血性腹泻和腹痛为特征的疾病。虽然波斯医学对 IBD 的一些定义和病因是基于体液理论,与当前的医学概念有所不同,但最近的研究表明,传统波斯医学对疾病的理解与 IBD 之间存在潜在的关系。波斯医学将患有特定疾病的患者分为不同类型的疾病,称为 "系统"(dystemperament),这些差异的应用被称为 "综合征分化"(syndrome differentiation)。这些传统分类需要不同的治疗方法。研究已经深入探讨了体液理论的分子基础以及综合征分化对包括 IBD 患者在内的患者药物选择的影响。然而,要探索波斯医学在治疗 IBD 方面的潜在疗效,了解这一古老的分类系统如何有助于改善疾病管理,还需要进一步的研究。
{"title":"A review of inflammatory bowel disease from the perspective of Persian medicine","authors":"Fatemeh sadat Hasheminasab ,&nbsp;Maryam Azimi","doi":"10.1016/j.explore.2024.103041","DOIUrl":"10.1016/j.explore.2024.103041","url":null,"abstract":"<div><p>The initial descriptions of inflammatory bowel disease (IBD) have been a topic of discussion. Cases of persistent diarrhea have been documented as far back as ancient Greece, with even Hippocrates (∼ 460–370 BCE) exploring various potential causes of diarrhea. Persian medicine was the predominant medical practice in the Eurasia region until the 18th century and had roots in Hippocrates and the ancient civilization of the region. Scholars, such as Avicenna (980–1025 CE), extensively described a disease characterized by intestinal ulcers, bloody diarrhea, and abdominal pain in the early medieval period. While some of the definitions and etiologies of IBD in Persian medicine are based on humoral theories that differ from current medical concepts, recent studies have suggested a potential relationship between the traditional Persian medicine understanding of the disease and IBD. Persian medicine classifies patients with specific diseases into different types of disorders known as dystemperament, with the application of these differences referred to as \"syndrome differentiation.\" These traditional classifications require distinct therapeutic approaches. Research has delved into the molecular bases of the humoral theory and the impact of syndrome differentiation on drug selection for patients, including those with IBD. However, further research is needed to explore the potential effectiveness of Persian medicine in treating IBD and to understand how this ancient classification system can contribute to improved disease management.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103041"},"PeriodicalIF":1.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Berberine as adjuvant therapy for treating reduced fertility potential in women with polycystic ovary syndrome: A meta-analysis of randomized controlled trials 小檗碱作为辅助疗法治疗多囊卵巢综合征妇女生育能力下降:随机对照试验荟萃分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-21 DOI: 10.1016/j.explore.2024.103040
Sifu Ha , Xiaoyu Song

Objective

To evaluate the effect of berberine as adjuvant therapy for the treatment of reduced fertility potential in women with polycystic ovary syndrome (PCOS) through a meta-analysis.

Methods

We comprehensively searched CNKI, SinoMed, Wanfang, Cochrane Library, PubMed, Embase databases to identify randomized controlled trials (RCTs) evaluating the effect of berberine as adjuvant therapy for treating reduced fertility potential in women with PCOS.

Results

A total of 10 RCTs involving 713 patients were included. Berberine in combination with Western medicine significantly improved endometrial thickness (weight mean difference [WMD] 1.62 mm; 95 % confidence interval [CI] 1.39–1.85), ovulation rate (risk ratio [RR] 1.41; 95 % CI 1.26–1.60), and clinical pregnancy rate (RR 1.96; 95 % CI 1.59–2.41) compared to Western medicine alone. Moreover, berberine as adjuvant therapy also significantly reduced the blood levels of luteinizing hormone (WMD -2.07 U/L; 95 % CI -2.62 to -1.51) and total testosterone (standard mean difference -0.70; 95 % CI -1.02 to -0.39) but not the level of follicle-stimulating hormone level (WMD -0.23 IU/L; 95 % CI -0.52 to 0.06).

Conclusions

Berberine may serve as an adjuvant therapy to enhance ovulation and increase clinical pregnancy rates in women with PCOS. The potential advantages of berberine may be linked to improvements in endometrial thickness, total testosterone, and luteinizing hormone level. However, further clinical trials are needed to confirm these findings and establish definitive conclusions.

方法 我们全面检索了CNKI、SinoMed、Wanfang、Cochrane Library、PubMed、Embase等数据库,以确定评估小檗碱作为辅助疗法治疗多囊卵巢综合征(PCOS)女性生育力下降效果的随机对照试验(RCT)。结果 共纳入10项RCT,涉及713例患者。与单独使用西药相比,小檗碱与西药联合使用可显著改善子宫内膜厚度(重量平均差 [WMD] 1.62 mm; 95 % 置信区间 [CI] 1.39-1.85)、排卵率(风险比 [RR] 1.41; 95 % CI 1.26-1.60)和临床妊娠率(RR 1.96; 95 % CI 1.59-2.41)。此外,小檗碱作为辅助疗法还能显著降低血中黄体生成素水平(WMD -2.07 U/L;95 % CI -2.62 to -1.51 )和总睾酮水平(标准平均差 -0.70 ;95 % CI -1.02 to -0.结论小檗碱可作为一种辅助疗法,促进多囊卵巢综合征妇女的排卵并提高临床妊娠率。小檗碱的潜在优势可能与子宫内膜厚度、总睾酮和黄体生成素水平的改善有关。不过,还需要进一步的临床试验来证实这些发现并得出明确的结论。
{"title":"Berberine as adjuvant therapy for treating reduced fertility potential in women with polycystic ovary syndrome: A meta-analysis of randomized controlled trials","authors":"Sifu Ha ,&nbsp;Xiaoyu Song","doi":"10.1016/j.explore.2024.103040","DOIUrl":"10.1016/j.explore.2024.103040","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effect of berberine as adjuvant therapy for the treatment of reduced fertility potential in women with polycystic ovary syndrome (PCOS) through a meta-analysis.</p></div><div><h3>Methods</h3><p>We comprehensively searched CNKI, SinoMed, Wanfang, Cochrane Library, PubMed, Embase databases to identify randomized controlled trials (RCTs) evaluating the effect of berberine as adjuvant therapy for treating reduced fertility potential in women with PCOS.</p></div><div><h3>Results</h3><p>A total of 10 RCTs involving 713 patients were included. Berberine in combination with Western medicine significantly improved endometrial thickness (weight mean difference [WMD] 1.62 mm; 95 % confidence interval [CI] 1.39–1.85), ovulation rate (risk ratio [RR] 1.41; 95 % CI 1.26–1.60), and clinical pregnancy rate (RR 1.96; 95 % CI 1.59–2.41) compared to Western medicine alone. Moreover, berberine as adjuvant therapy also significantly reduced the blood levels of luteinizing hormone (WMD -2.07 U/L; 95 % CI -2.62 to -1.51) and total testosterone (standard mean difference -0.70; 95 % CI -1.02 to -0.39) but not the level of follicle-stimulating hormone level (WMD -0.23 IU/L; 95 % CI -0.52 to 0.06).</p></div><div><h3>Conclusions</h3><p>Berberine may serve as an adjuvant therapy to enhance ovulation and increase clinical pregnancy rates in women with PCOS. The potential advantages of berberine may be linked to improvements in endometrial thickness, total testosterone, and luteinizing hormone level. However, further clinical trials are needed to confirm these findings and establish definitive conclusions.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103040"},"PeriodicalIF":1.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indigenous land-based practices for climate crisis adaptions 适应气候危机的本土土地实践
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-20 DOI: 10.1016/j.explore.2024.103042
Ranjan Datta , Jebunnessa Chapola , Kara Owen , Margot Hurlbert , Audra Foggin

Indigenous communities across Canada persist at the forefront of environmental and climate-related challenges, necessitating a concerted effort to integrate traditional Indigenous land-based knowledge and practices that inherently promote environmental protection and resilience. Using a decolonial feminist theoretical framework, this research centers on Indigenous community perspectives on the climate crisis and their land-based adaptions. Such an approach empowers Indigenous communities to reclaim agency over their narratives and shape research agendas congruent with their lived realities and aspirations. The study concludes by promoting the imperative of revitalizing traditional Indigenous land-based knowledge, practices and relationships with their ancestral lands. Despite emerging recognition within the scientific literature and international agreements, such as the Paris Agreement, of the significance of traditional Indigenous land-based knowledge, many climate mitigation and adaptation initiatives continue to overlook Indigenous participation at various decision-making junctures. Hence, this paper advocates the necessity for international frameworks to acknowledge and integrate traditional knowledge systems and Indigenous participation across national borders, fostering inclusive climate crisis solutions that resonate with Indigenous communities' perspectives and experiences.

加拿大各地的原住民社区一直处于环境和气候相关挑战的前沿,因此有必要共同努力,整合传统的原住民土地知识和实践,从本质上促进环境保护和复原力。本研究采用非殖民地女权主义理论框架,以土著社区对气候危机的看法及其基于土地的适应措施为中心。这种方法赋予了土著社区权力,使其能够重新掌握自己的叙述,并制定符合其生活现实和愿望的研究议程。本研究最后提倡,必须振兴传统的土著土地知识、实践以及与祖先土地的关系。尽管科学文献和《巴黎协定》等国际协定逐渐认识到传统土著土地知识的重要性,但许多气候减缓和适应倡议仍然忽视土著人在各种决策关头的参与。因此,本文主张国际框架必须承认并整合传统知识体系和土著人的跨国参与,促进与土著社区的观点和经验产生共鸣的包容性气候危机解决方案。
{"title":"Indigenous land-based practices for climate crisis adaptions","authors":"Ranjan Datta ,&nbsp;Jebunnessa Chapola ,&nbsp;Kara Owen ,&nbsp;Margot Hurlbert ,&nbsp;Audra Foggin","doi":"10.1016/j.explore.2024.103042","DOIUrl":"10.1016/j.explore.2024.103042","url":null,"abstract":"<div><p>Indigenous communities across Canada persist at the forefront of environmental and climate-related challenges, necessitating a concerted effort to integrate traditional Indigenous land-based knowledge and practices that inherently promote environmental protection and resilience. Using a decolonial feminist theoretical framework, this research centers on Indigenous community perspectives on the climate crisis and their land-based adaptions. Such an approach empowers Indigenous communities to reclaim agency over their narratives and shape research agendas congruent with their lived realities and aspirations. The study concludes by promoting the imperative of revitalizing traditional Indigenous land-based knowledge, practices and relationships with their ancestral lands. Despite emerging recognition within the scientific literature and international agreements, such as the Paris Agreement, of the significance of traditional Indigenous land-based knowledge, many climate mitigation and adaptation initiatives continue to overlook Indigenous participation at various decision-making junctures. Hence, this paper advocates the necessity for international frameworks to acknowledge and integrate traditional knowledge systems and Indigenous participation across national borders, fostering inclusive climate crisis solutions that resonate with Indigenous communities' perspectives and experiences.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103042"},"PeriodicalIF":1.9,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1550830724001496/pdfft?md5=dfb8adc20c9fe670e5985865c75228ae&pid=1-s2.0-S1550830724001496-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualized homeopathic medicines in the treatment of premenstrual syndrome: A double-blind, randomized, placebo-controlled trial 治疗经前综合征的个性化顺势疗法药物:双盲、随机、安慰剂对照试验
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-17 DOI: 10.1016/j.explore.2024.103039
Sanjib Sahoo , Chintamani Nayak , Prasanta Rath , Soumya Bhattacharya , Suranjana Mukherjee , Abhijit Dutta

Introduction

Background: Premenstrual syndrome (PMS) is a common disorder among female population that adversely affects their physical and emotional well-being. Conventional treatments for PMS may have limitations and side effects, prompting a need for complementary therapeutic approaches. This double-blind, randomized, placebo-controlled trial aimed to investigate the efficacy of individualized Homeopathic medicines (IH) in treating PMS symptoms in comparison to placebo (PL).

Methods

This study recruited female participants of reproductive age who had been experiencing premenstrual syndrome (PMS) for >3 months, from the Outpatient Department. The participants were randomly assigned to receive either IH or PL. The measured outcomes included the Shortened Premenstrual Assessment Form (SPAF) questionnaire as the primary outcome, and the Premenstrual Tension Syndrome Visual Analogue Scale (PMTS-VAS) and the Premenstrual Tension Syndrome Observer Rating Scale – Revised (PMTS-OR) as secondary outcomes. These measures were assessed at baseline and every month for 3 months.

Results

The results showed a statistically significant reduction in total SPAF scores for the IH group compared to the placebo group (F = 11.340; P < 0.001) at month 2 (-5.5 ± 1.8, P = 0.003), and month 3 (-6.6 ± 2.0, P = 0.002). Additionally, there were significant reductions in PMTS-VAS and PMTS-OR scores in the IH compared to placebo group. Natrum muriaticum (n = 4/30, 13.3 %) was the most frequently indicated medicines in the study. Four adverse events (13.33 %) occurred in the IH group, and six adverse events (16.67 %) in the Placebo group, with no serious events reported, and no additional medicinal treatment was required for participants during the study period.

Conclusions

Individualized Homeopathic medicines were found to be significantly effective, compared to placebo in reducing PMS symptoms. Further independent replication is warranted to validate and corroborate these findings, as well as to identify the most effective Homeopathic medicines for treating PMS symptoms. Until then, clinicians may consider these findings when exploring personalized and holistic therapeutic strategies for managing PMS.

Trial Registration

CTRI/2020/11/028,796, dt. 02/11/2020

导言背景:经前期综合征(PMS)是女性人群中常见的一种疾病,对她们的身心健康造成了不利影响。经前期综合征的传统治疗方法可能存在局限性和副作用,因此需要辅助治疗方法。这项双盲、随机、安慰剂对照试验旨在研究个体化顺势疗法药物(IH)与安慰剂(PL)相比在治疗经前综合征症状方面的疗效。参与者被随机分配接受 IH 或 PL 治疗。测量结果包括作为主要结果的经前期评估简表(SPAF)问卷,以及作为次要结果的经前期紧张综合征视觉模拟量表(PMTS-VAS)和经前期紧张综合征观察者评定量表-修订版(PMTS-OR)。结果表明,与安慰剂组相比,IH 组 SPAF 总分在第 2 个月(-5.5 ± 1.8,P = 0.003)和第 3 个月(-6.6 ± 2.0,P = 0.002)显著降低(F = 11.340; P < 0.001)。此外,与安慰剂组相比,IH组的PMTS-VAS和PMTS-OR评分明显降低。本研究中最常使用的药物是硝酸甘油(4/30,13.3%)。IH组发生了4起不良事件(13.33%),安慰剂组发生了6起不良事件(16.67%),没有严重事件报告,参与者在研究期间不需要额外的药物治疗。为了验证和证实这些研究结果,并确定治疗经前综合征症状最有效的顺势疗法药物,有必要进一步进行独立复制。在此之前,临床医生在探索经前综合征的个性化整体治疗策略时,可以考虑这些研究结果。试验注册CTRI/2020/11/028,796, dt.02/11/2020
{"title":"Individualized homeopathic medicines in the treatment of premenstrual syndrome: A double-blind, randomized, placebo-controlled trial","authors":"Sanjib Sahoo ,&nbsp;Chintamani Nayak ,&nbsp;Prasanta Rath ,&nbsp;Soumya Bhattacharya ,&nbsp;Suranjana Mukherjee ,&nbsp;Abhijit Dutta","doi":"10.1016/j.explore.2024.103039","DOIUrl":"10.1016/j.explore.2024.103039","url":null,"abstract":"<div><h3>Introduction</h3><p>Background: Premenstrual syndrome (PMS) is a common disorder among female population that adversely affects their physical and emotional well-being. Conventional treatments for PMS may have limitations and side effects, prompting a need for complementary therapeutic approaches. This double-blind, randomized, placebo-controlled trial aimed to investigate the efficacy of individualized Homeopathic medicines (IH) in treating PMS symptoms in comparison to placebo (PL).</p></div><div><h3>Methods</h3><p>This study recruited female participants of reproductive age who had been experiencing premenstrual syndrome (PMS) for &gt;3 months, from the Outpatient Department. The participants were randomly assigned to receive either IH or PL. The measured outcomes included the Shortened Premenstrual Assessment Form (SPAF) questionnaire as the primary outcome, and the Premenstrual Tension Syndrome Visual Analogue Scale (PMTS-VAS) and the Premenstrual Tension Syndrome Observer Rating Scale – Revised (PMTS-OR) as secondary outcomes. These measures were assessed at baseline and every month for 3 months.</p></div><div><h3>Results</h3><p>The results showed a statistically significant reduction in total SPAF scores for the IH group compared to the placebo group (<em>F</em> = 11.340; <em>P</em> &lt; 0.001) at month 2 (-5.5 ± 1.8, <em>P</em> = 0.003), and month 3 (-6.6 ± 2.0, <em>P</em> = 0.002). Additionally, there were significant reductions in PMTS-VAS and PMTS-OR scores in the IH compared to placebo group. <em>Natrum muriaticum</em> (<em>n</em> = 4/30, 13.3 %) was the most frequently indicated medicines in the study. Four adverse events (13.33 %) occurred in the IH group, and six adverse events (16.67 %) in the Placebo group, with no serious events reported, and no additional medicinal treatment was required for participants during the study period.</p></div><div><h3>Conclusions</h3><p>Individualized Homeopathic medicines were found to be significantly effective, compared to placebo in reducing PMS symptoms. Further independent replication is warranted to validate and corroborate these findings, as well as to identify the most effective Homeopathic medicines for treating PMS symptoms. Until then, clinicians may consider these findings when exploring personalized and holistic therapeutic strategies for managing PMS.</p></div><div><h3>Trial Registration</h3><p>CTRI/2020/11/028,796, dt. 02/11/2020</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103039"},"PeriodicalIF":1.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142098822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liberation from extracorporeal membrane oxygenation in a patient with severe COVID-19-associated acute respiratory distress syndrome using traditional Chinese medicine: A case report 用中药使一名重度 COVID-19 相关急性呼吸窘迫综合征患者摆脱体外膜氧合:病例报告
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-10 DOI: 10.1016/j.explore.2024.103038
Hsuan-Ting Tang , Sheng-Teng Huang , Shi-Chen Ou

Introduction

Due to the continued threat to public health posed by SARS-CoV-2 and the ongoing emergence of novel variants, the integration of traditional Chinese medicine (TCM) with Western medicine provides a novel alternative management for critically ill patients.

Case presentation

This case report describes a 54-year-old male with severe COVID-19-associated acute respiratory distress syndrome (ARDS) who required extracorporeal membrane oxygenation (ECMO) support. Despite standard treatment, ECMO liberation was unsuccessful, and complications such as pneumothorax and hemothorax ensued. However, upon initiating combined TCM therapy on the 19th day of ECMO support, the patient exhibited gradual improvements in oxygenation and ventilation, leading to successful ECMO liberation on the 31st day.

Conclusion

This case underscores the potential of integrating TCM with conventional therapies for severe COVID-19 cases, offering a valuable treatment option amidst the evolving landscape of SARS-CoV-2 variants.

导言由于 SARS-CoV-2 对公众健康的持续威胁以及新型变种的不断出现,传统中医药(TCM)与西医的结合为危重病人提供了一种新的替代治疗方法。本病例报告描述了一名 54 岁男性患者,他患有严重的 COVID-19 相关急性呼吸窘迫综合征(ARDS),需要体外膜氧合(ECMO)支持。尽管进行了规范治疗,但 ECMO 解痉治疗仍不成功,随后出现了气胸和血胸等并发症。然而,在 ECMO 支持的第 19 天开始联合中医治疗后,患者的氧合和通气情况逐渐改善,最终在第 31 天成功脱离 ECMO。
{"title":"Liberation from extracorporeal membrane oxygenation in a patient with severe COVID-19-associated acute respiratory distress syndrome using traditional Chinese medicine: A case report","authors":"Hsuan-Ting Tang ,&nbsp;Sheng-Teng Huang ,&nbsp;Shi-Chen Ou","doi":"10.1016/j.explore.2024.103038","DOIUrl":"10.1016/j.explore.2024.103038","url":null,"abstract":"<div><h3>Introduction</h3><p>Due to the continued threat to public health posed by SARS-CoV-2 and the ongoing emergence of novel variants, the integration of traditional Chinese medicine (TCM) with Western medicine provides a novel alternative management for critically ill patients.</p></div><div><h3>Case presentation</h3><p>This case report describes a 54-year-old male with severe COVID-19-associated acute respiratory distress syndrome (ARDS) who required extracorporeal membrane oxygenation (ECMO) support. Despite standard treatment, ECMO liberation was unsuccessful, and complications such as pneumothorax and hemothorax ensued. However, upon initiating combined TCM therapy on the 19th day of ECMO support, the patient exhibited gradual improvements in oxygenation and ventilation, leading to successful ECMO liberation on the 31st day.</p></div><div><h3>Conclusion</h3><p>This case underscores the potential of integrating TCM with conventional therapies for severe COVID-19 cases, offering a valuable treatment option amidst the evolving landscape of SARS-CoV-2 variants.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103038"},"PeriodicalIF":1.9,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142044627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of mindfulness-based stress reduction therapy for sleep quality and perceived stress in patients with spinal cord injury 正念减压疗法对脊髓损伤患者睡眠质量和感知压力的影响
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-08-08 DOI: 10.1016/j.explore.2024.103037
Yan Cao, Huihong Wu, Sujuan Shi, Dan Xie

Objective

To explore the effect of the mindfulness-based stress reduction (MBSR) practice on sleep quality and perceived stress in patients with spinal cord injury (SCI).

Method

A total of 104 patients with SCI (diagnosed via imaging and clinical symptoms) admitted to our hospital between January 2020 and December 2022 were selected as the study participants. The patients were randomly divided into two groups: the MBSR (observation) group and the control group. The observation group received MBSR therapy and routine nursing, and the control group received music training therapy and routine nursing. The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate sleep quality, and the perceived stress score was used to evaluate stress experienced by the patients at three timepoints: before intervention, 4 weeks and 8weeks after intervention.

Results

Compared with before intervention, the PSQI scores of both the control group and intervention group participants significantly decreased after intervention(P < 0.01). Compared with the 4 weeks after intervention, the PSQI scores of both groups of participants decreased in the 8 weeks after intervention(P < 0.01). There was a significant difference in PSQI scores between the two groups of participants at 4 and 8 weeks after intervention(P < 0.01). Compared with before intervention, the average perceived stress score of both the control group and intervention group participants significantly decreased after intervention(P < 0.05). Compared with the 4 weeks after intervention, the average perceived stress score of both groups of participants decreased in the 8 weeks after intervention(P < 0.01). There was a significant difference in average perceived stress score between the two groups of participants at 4(P < 0.05) and 8 weeks(P < 0.01) after intervention(P < 0.01).

Conclusion

The use of MBSR therapy could effectively improve patient sleep quality and reduce perceived stress.

方法 选取2020年1月至2022年12月期间我院收治的104例脊髓损伤(SCI)患者(通过影像学和临床症状确诊)作为研究对象。患者被随机分为两组:MBSR(观察)组和对照组。观察组接受 MBSR 治疗和常规护理,对照组接受音乐训练治疗和常规护理。采用匹兹堡睡眠质量指数(PSQI)评估睡眠质量,采用感知压力评分评估患者在干预前、干预后4周和干预后8周三个时间点的压力体验。结果与干预前相比,干预后对照组和干预组参与者的PSQI评分均显著下降(P< 0.01)。与干预后 4 周相比,干预后 8 周两组受试者的 PSQI 均有所下降(P < 0.01)。两组受试者在干预后 4 周和 8 周的 PSQI 分数有明显差异(P < 0.01)。与干预前相比,干预后对照组和干预组参与者的平均感知压力得分均明显下降(P <0.05)。与干预后 4 周相比,干预后 8 周两组参与者的平均感知压力得分均有所下降(P < 0.01)。两组受试者在干预后4周(P <0.05)和8周(P <0.01)的平均感知压力得分有明显差异(P <0.01)。
{"title":"Effects of mindfulness-based stress reduction therapy for sleep quality and perceived stress in patients with spinal cord injury","authors":"Yan Cao,&nbsp;Huihong Wu,&nbsp;Sujuan Shi,&nbsp;Dan Xie","doi":"10.1016/j.explore.2024.103037","DOIUrl":"10.1016/j.explore.2024.103037","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the effect of the mindfulness-based stress reduction (MBSR) practice on sleep quality and perceived stress in patients with spinal cord injury (SCI).</p></div><div><h3>Method</h3><p>A total of 104 patients with SCI (diagnosed via imaging and clinical symptoms) admitted to our hospital between January 2020 and December 2022 were selected as the study participants. The patients were randomly divided into two groups: the MBSR (observation) group and the control group. The observation group received MBSR therapy and routine nursing, and the control group received music training therapy and routine nursing. The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate sleep quality, and the perceived stress score was used to evaluate stress experienced by the patients at three timepoints: before intervention, 4 weeks and 8weeks after intervention.</p></div><div><h3>Results</h3><p>Compared with before intervention, the PSQI scores of both the control group and intervention group participants significantly decreased after intervention(<em>P</em> &lt; 0.01). Compared with the 4 weeks after intervention, the PSQI scores of both groups of participants decreased in the 8 weeks after intervention(<em>P</em> &lt; 0.01). There was a significant difference in PSQI scores between the two groups of participants at 4 and 8 weeks after intervention(<em>P</em> &lt; 0.01). Compared with before intervention, the average perceived stress score of both the control group and intervention group participants significantly decreased after intervention(<em>P</em> &lt; 0.05). Compared with the 4 weeks after intervention, the average perceived stress score of both groups of participants decreased in the 8 weeks after intervention(<em>P</em> &lt; 0.01). There was a significant difference in average perceived stress score between the two groups of participants at 4(<em>P</em> &lt; 0.05) and 8 weeks(<em>P</em> &lt; 0.01) after intervention(<em>P</em> &lt; 0.01).</p></div><div><h3>Conclusion</h3><p>The use of MBSR therapy could effectively improve patient sleep quality and reduce perceived stress.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 5","pages":"Article 103037"},"PeriodicalIF":1.9,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Near-death experience: memory recovery during hypnosis 濒死体验催眠过程中的记忆恢复
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-24 DOI: 10.1016/j.explore.2024.103036
Marjorie Woollacott

Increasing numbers of research studies have offered evidence regarding awareness of verified events during near-death experiences (NDEs) occurring during cardiac arrest and severely impaired brain function. The prevalence of patients reporting core NDEs under these conditions is reported as 10–12 %. One question that is often asked is why this percentage is low. Though it may be hypothesized that NDEs are limited to this low percentage of patients, it is also possible that more patients experience an NDE, but that memory is impaired sufficiently such that the NDE is not recalled. In this article I present a detailed and extensively verified case study of a woman, Stephanie Arnold, who experienced an NDE during the birth of her second child when she was 41 years old. The data provide evidence that supports the hypotheses 1) that during cardiac arrest an NDE may occur, but not be remembered until hypnotic regression therapy reveals extensive details of the events that could not have been perceived with the five senses, both in the operating room and elsewhere during resuscitation. 2) that there may also be pre-cognition of the events leading to the cardiac arrest, reported in clear detail, and 3) that NDEs lead to a fundamental transformation in an individual's understanding of the nature of consciousness, their quest for meaning and purpose, their concern for others, and their appreciation of life.

越来越多的研究提供了证据,证明在心脏骤停和脑功能严重受损的濒死体验(NDE)过程中,患者能够意识到已证实的事件。据报道,在这些情况下报告核心濒死体验的患者比例为 10-12%。人们经常问的一个问题是,为什么这个比例很低。虽然可以假设 NDE 仅限于这一低比例的患者,但也有可能有更多的患者经历过 NDE,但由于记忆力受损而无法回忆起 NDE。在这篇文章中,我介绍了一个详细且经过广泛验证的案例研究,研究对象是一位名叫斯蒂芬妮-阿诺德的女性,她在 41 岁时生第二个孩子时经历了一次 NDE。这些数据提供了支持以下假设的证据:1)在心脏骤停期间,可能会发生 NDE,但直到催眠回归疗法揭示了在手术室和复苏期间五官无法感知的事件的大量细节后,才会被记起。2) 对导致心脏骤停的事件也可能有预先认知,并有清晰的细节报告;以及 3) NDE 会导致个人对意识本质的理解、对意义和目的的追求、对他人的关心以及对生命的珍惜发生根本性转变。
{"title":"Near-death experience: memory recovery during hypnosis","authors":"Marjorie Woollacott","doi":"10.1016/j.explore.2024.103036","DOIUrl":"10.1016/j.explore.2024.103036","url":null,"abstract":"<div><p>Increasing numbers of research studies have offered evidence regarding awareness of verified events during near-death experiences (NDEs) occurring during cardiac arrest and severely impaired brain function. The prevalence of patients reporting core NDEs under these conditions is reported as 10–12 %. One question that is often asked is why this percentage is low. Though it may be hypothesized that NDEs are limited to this low percentage of patients, it is also possible that more patients experience an NDE, but that memory is impaired sufficiently such that the NDE is not recalled. In this article I present a detailed and extensively verified case study of a woman, Stephanie Arnold, who experienced an NDE during the birth of her second child when she was 41 years old. The data provide evidence that supports the hypotheses 1) that during cardiac arrest an NDE may occur, but not be remembered until hypnotic regression therapy reveals extensive details of the events that could not have been perceived with the five senses, both in the operating room and elsewhere during resuscitation. 2) that there may also be pre-cognition of the events leading to the cardiac arrest, reported in clear detail, and 3) that NDEs lead to a fundamental transformation in an individual's understanding of the nature of consciousness, their quest for meaning and purpose, their concern for others, and their appreciation of life.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103036"},"PeriodicalIF":1.9,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141784567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Explore-The Journal of Science and Healing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1